We developed an endosomal pH-responsive nanoparticle to carry the Rac1 siRNAs together with cisplatin, which resulted in an effective delivery of the Rac1 targeting oligonucleotide and cisplatin in breast tumors and exhibited a promising synergetic anti-tumor effect. This evidence concerns the gene RAC1 and breast neoplasm.